Şunu aradınız:: karateristiċi (Maltaca - İngilizce)

karateristiĊi metroloĠiĊi
metrological characteristics

karateristiċi organolettiċi:
organoleptic characteristics:

karateristiċi ta' kont bażiku ta' ħlas
characteristics of a basic payment account

il-karateristiċi tagħhom skond in-nomenklatura tar-rifużjoni,
their characteristics in terms of the refund nomenclature,

il-karateristiċi speċifiċi tal-marda fl-ispeċi kkonċernat, u
the specific characteristics of the disease in the species concerned, and

dawn il-karateristiċi komuni jiffurmaw il-punt fokali ta' din il-komunikazzjoni.
these commonalities will form the focus of this communication.

il-karateristiċi farmakokinetiċi disponibbli hija limitata f’pazjenti anzjani bid-dijabete mellitus.
limited pharmacokinetic data are available in elderly patients with diabetes mellitus.

anzjani il- karateristiċi farmakokinetiċi disponibbli hija limitata f’ pazjenti anzjani bid- dijabete mellitus.
elderly limited pharmacokinetic data are available in elderly patients with diabetes mellitus.

(ċ) definizzjonijiet skond il-kas, b'mod partikolari karateristiċi kliniki u mikrobioloġiċi;
case definitions, in particular clinical and microbiological characteristics;

il-karateristiċi farmakokinetiċi ta’ l-insulina glulisine ġeneralment dehru f’pazjenti b’indeboliment renali.
the pharmacokinetic properties of insulin glulisine are generally maintained in patients with renal impairment.

il-karateristiċi farmakokinetiċi ta’ l-insulina glulisine ġeneralment dehru mantnut f’pazjenti b’indeboliment renali.
the pharmacokinetic properties of insulin glulisine are generally maintained in patients with renal impairment.

itejbu d-definizzjoni u tħaddim tal-policies ewropej kif ukoll nazzjonali billi jadottawhom għall-karateristiċi partikulari tat-territorji,
improve the definition and implementation of both european and national policies, adapting them to the specific characteristics of these areas;

indeboliment renali il- karateristiċi farmakokinetiċi ta ’ l- insulina glulisine ġeneralment dehru mantnut f’ pazjenti b’ indeboliment renali.
renal impairment the pharmacokinetic properties of insulin glulisine are generally maintained in patients with renal impairment.

il-karateristiċi, li għalihom trid tiġi kkumpilata l-istatistika dwar il-ħidmiet ta’ rkupru u disponiment, kif msemmija fit-taqsima 8(2), huma ddikjarati fit-tabella ta’ hawn taħt.
the characteristics, for which the statistics are to be compiled on recovery and disposal operations, as referred to in section 8(2) are set out in the table below.